Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Breast Disease(Electronic Edition) ›› 2014, Vol. 08 ›› Issue (02): 103-108. doi: 10.3877/cma. j. issn.1674-0807.2014.02.007

• Original Articles • Previous Articles     Next Articles

Comparison of totally implantable venous-access port and peripherally inserted central catheter in chemotherapy of breast cancer patients

Tieqiang Bi1, Jun Zhou1,(), Rui Wang1, Hai Liu1   

  1. 1.Department of Thyroid and Breast Surgery, First People’s Hospital of Lianyungang City, Lianyungang 222002, China
  • Received:2013-07-15 Online:2014-04-01 Published:2024-12-05
  • Contact: Jun Zhou

Abstract:

Objective

To compare peripherally inserted central catheter (PICC) and totally implantable venous-access port (TIVAP) in breast cancer patients with intravenous chemotherapy.

Methods

Totally 297 breast cancer patients who underwent postoperative chemotherapy after breast cancer surgery in our department from May 2011 to April 2013 were divided into PICC group (n=187) and TIVAP group (n=110). Successful catheterization rate, complication rate and quality of life during intravenous chemotherapy were compared. All data were analyzed using t test and Chi-square test.

Results

The successful one-time catheterization rate in TIVAP group was slightly lower than that in PICC group [84.55%(93/110)vs 92.51%(173/187),χ2=4.70,P=0.03]; complication rate in TIVAP group was lower than that in PICC group [1.82%(2/110)vs 9.09%(17/187),χ2 =6.12,P=0.01]; compared with TIVAP group, the quality of life of patients in PICC group declined significantly [the proportion of the patients with good life quality in PICC group vs that in TIVAP group: 90%(170/187)vs 100%(110/110),χ2=10.61, P=0.00].

Conclusion

In spite of higher cost and more complicated operation, TIVAP has some advantages over PICC, such as longer retention time, fewer complications, longer catheter maintenance intervals and less impact on life quality of patients,which is feasible for intravenous chemotherapy in breast cancer patients.

Key words: Catheterization, central vein, Infusion pumps, implantable, Breast neoplasms, Chemotherapy

京ICP 备07035254号-13
Copyright © Chinese Journal of Breast Disease(Electronic Edition), All Rights Reserved.
Tel: 0086-10-51322630 E-mail: jcbd@medmail.com.cn
Powered by Beijing Magtech Co. Ltd